Search Within

Philip O Livingston

Formats
  1. Journal Article (152)
  2. Meeting Abstract (65)
  3. Book Section (8)
  4. Conference Paper (3)
Groups
  1. Department of Medicine (161)
  2. Solid Tumor Oncology Division (157)
  3. Melanoma and Immunotherapeutics Service (148)
  4. Melanoma Disease Management Team (120)
  5. Sloan Kettering Institute Faculty (81)
  6. Molecular Pharmacology and Chemistry Program Faculty (53)

More Groups

People
  1. Govindaswami Ragupathi (118)
  2. Samuel Danishefsky (46)
  3. Kenneth Lloyd (32)
  4. Paul Chapman (30)
  5. Alan Houghton (28)
  6. Shengle Zhang (25)

More People

Years
  1. 2017 (1)
  2. 2014 (3)
  3. 2013 (1)
  4. 2012 (2)
  5. 2011 (8)
  6. 2010 (6)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (38)
  2. Cancer Research (25)
  3. Clinical Cancer Research (21)
  4. Cancer Immunology, Immunotherapy (18)
  5. International Journal of Cancer (12)
  6. Vaccine (11)

More Publications

Publishers
  1. American Association for Cancer Research (84)
  2. Springer (24)
  3. Elsevier Inc. (17)
  4. American Chemical Society (16)
  5. John Wiley & Sons (15)
  6. American Society of Clinical Oncology (10)

More Publishers

Results (228)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial immunological adjuvant QS-21 with a GM2 ganglioside-KLH conjugate vaccine in patients with malignant melanoma
    Meeting Abstract

    Helling, F.; Livingston, P. O.; Adluri, S.; Shang, A.; Yao, T. J.; Kensil, C. R.; Newman, M. J.; Marciani, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Phase I trial of immunological adjuvant SAFm in melanoma patients vaccinated with antiidiotype antibody MELIMMUNE-1
    Journal Article

    Livingston, P. O.; Adluri, S.; Raychaudhuri, S.; Hughes, M. H.; Calves, M. J.; Merritt, J. A.
    Vaccine Research (1994)

    Fulltext@MSK | Save
  • Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
    Journal Article

    Livingston, P. O.; Adluri, S.; Helling, F.; Yao, T. J.; Kensilt, C. R.; Newman, M. J.; Marciani, D.
    Vaccine (1994)

    Fulltext@MSK | Save
  • Immunization of melanoma patients with antiidiotypic monoclonal antibody BEC2 (which mimics GD3 ganglioside): Pilot trials using no immunological adjuvant
    Journal Article

    Chapman, P. B.; Livingston, P. O.; Morrison, M. E.; Williams, L.; Houghton, A. N.
    Vaccine Research (1994)

    Fulltext@MSK | Save
  • Ganglioside conjugate vaccines: Immunotherapy against tumors of neuroectodermal origin
    Journal Article

    Helling, F.; Livingston, P. O.
    Molecular and Chemical Neuropathology (1994)

    Fulltext@MSK | Save
  • Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside
    Journal Article

    Livingston, P. O.; Wong, G. Y. C.; Adluri, S.; Tao, Y.; Padavan, M.; Parente, R.; Hanlon, C.; Calves, M. J.; Helling, F.; Ritter, G.; more...
    Journal of Clinical Oncology (1994)

    Fulltext@MSK | Save
  • G(D3) vaccines for melanoma: Superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines
    Journal Article

    Helling, F.; Shang, A.; Calves, M.; Zhang, S.; Ren, S.; Yu, R. K.; Oettgen, H. F.; Livingston, P. O.
    Cancer Research (1994)

    Fulltext@MSK | Save
  • Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3
    Journal Article

    Ren, S.; Ariga, T.; Scarsdale, J. N.; Zhang, Y.; Slominski, A.; Livingston, P. O.; Ritter, G.; Kushi, Y.; Yu, R. K.
    Journal of Lipid Research (1993)

    Fulltext@MSK | Save
  • GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3
    Journal Article

    Livingston, P. O.; Calves, M. J.; Helling, F.; Zollinger, W. D.; Blake, M. S.; Lowell, G. H.
    Vaccine (1993)

    Fulltext@MSK | Save
  • Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatography
    Journal Article

    Hamilton, W. B.; Helling, F.; Lloyd, K. O.; Livingston, P. O.
    International Journal of Cancer (1993)

    Fulltext@MSK | Save